Millicom International Cellular
TIGO
90.77
+0.31
+0.34%
Millicom International Cellular
US · TIGO
#1146 by market cap
Listed 1970
90.77
+0.31
+0.34%
Live - 5344 symbols - heartbeat 482s ago
· 2026-10-07 20:01
After-hours
90.77
0.00%
- Market cap
- 15.22B
- P/E (TTM)i
- 22.75
- P/Bi
- 6.20
- EPSi
- 7.83
- Div yieldi
- 3.31%
- 52W posi
- 75%
Reader sentiment
Are you bullish or bearish on TIGO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.52, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +0.26% YoY
Margins
- Gross margin
- 77.45%
- Operating margin
- 25.83%
- Net margin
- 22.62%
Key ratios & quality
- Enterprise valuei
- 20.85B
- PEG ratioi
- 0.24
- Altman Z-Scorei
- 1.52
PEG uses trailing P/E against the 3-year net income growth rate (95.18%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | 4.34B | 3.81B | 4.26B | 5.62B | 5.66B | 5.80B | 5.82B |
| Gross profit | 2.83B | 3.14B | 2.75B | 3.06B | 4.12B | 4.15B | 4.38B | 4.51B |
| Selling & admin expenses | 1.04B | 899.00M | 802.00M | 924.00M | 1.06B | 1.15B | 1.08B | 995.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 423.00M | 436.00M | 252.00M | 415.00M | 885.00M | 779.00M | 1.27B | 1.50B |
| Pretax profit | 119.00M | 218.00M | -252.00M | 728.00M | 238.00M | 175.00M | 552.00M | 1.67B |
| Tax | 112.00M | 120.00M | 72.00M | 158.00M | 222.00M | 424.00M | 281.00M | 303.00M |
| Net profit | -26.00M | 154.00M | -385.00M | 542.00M | 129.00M | -245.00M | 268.00M | 1.36B |
| Basic EPS | 0 | 1 | -3 | 5 | 1 | 0 | 1 | 8 |
| Diluted EPS | -0.08 | 1.16 | -2.68 | 4.57 | 1.27 | 0.48 | 1.47 | 7.86 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.37B | 1.37B | 1.42B | 1.65B | 1.99B | 2.18B |
| Gross profit | 1.05B | 1.05B | 1.11B | 1.29B | 1.51B | 1.64B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 408.00M | 341.00M | 376.00M | 405.00M | 427.00M | 452.00M |
| Pretax profit | 287.00M | 772.00M | 289.00M | 312.00M | 154.00M | 204.00M |
| Tax | 71.00M | 101.00M | 85.00M | 45.00M | 78.00M | 104.00M |
| Net profit | 219.00M | 673.00M | 204.00M | 266.00M | 75.00M | 101.00M |
| Basic EPS | 1 | 4 | 1 | 2 | 1 | 1 |
| Diluted EPS | 1.14 | 4.03 | 1.16 | 1.50 | 0.65 | 0.65 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.53B | 2.66B | 2.31B | 2.25B | 2.07B | 1.92B | 2.38B | 2.98B |
| Cash & ST investments | 528.00M | 1.54B | 1.04B | 895.00M | 1.04B | 775.00M | 699.00M | 1.55B |
| Inventory | 39.00M | 32.00M | 37.00M | 63.00M | 53.00M | 45.00M | 44.00M | 70.00M |
| Total assets | 10.31B | 12.90B | 12.42B | 15.14B | 14.20B | 14.52B | 13.74B | 17.25B |
| Total current liabilities | 2.68B | 2.42B | 2.61B | 4.49B | 2.12B | 2.33B | 3.12B | 3.39B |
| Short-term debt | 457.00M | 293.00M | 236.00M | 2.01B | 343.00M | 410.00M | 438.00M | 622.00M |
| Long-term debt | 3.77B | 5.79B | 5.58B | 5.90B | 6.62B | 6.48B | 5.53B | 6.56B |
| Total liabilities | 7,520,000,000.00 | 10,214,000,000.00 | 10,148,000,000.00 | 12,401,000,000.00 | 10,564,000,000.00 | 11,071,000,000.00 | 10,163,000,000.00 | 13,633,000,000.00 |
| Total equity | 2.79B | 2.68B | 2.27B | 2.74B | 3.63B | 3.45B | 3.57B | 3.62B |
| Retained earnings | 2.53B | 2.37B | 2.02B | 2.61B | 2.87B | 2.70B | 2.88B | 3.09B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.22B | 2.83B | 3.13B | 2.98B | 3.11B | 2.80B |
| Cash & ST investments | 534.00M | 1.28B | 1.66B | 1.55B | 1.18B | 861.00M |
| Inventory | 56.00M | 74.00M | 68.00M | 70.00M | 97.00M | 101.00M |
| Total assets | 13.66B | 15.00B | 15.59B | 17.25B | 20.75B | 20.68B |
| Total current liabilities | 2.92B | 3.19B | 3.37B | 3.39B | 5.05B | 5.18B |
| Short-term debt | 409.00M | 556.00M | 656.00M | 622.00M | 1.56B | 1.45B |
| Long-term debt | 5.52B | 5.56B | 5.82B | 6.56B | 7.39B | 7.65B |
| Total liabilities | 10,309,000,000.00 | 11,502,000,000.00 | 12,280,000,000.00 | 13,633,000,000.00 | 17,577,000,000.00 | 18,186,000,000.00 |
| Total equity | 3.35B | 3.50B | 3.31B | 3.62B | 3.17B | 2.49B |
| Retained earnings | 2.95B | 3.06B | 2.84B | 3.09B | 2.89B | 2.27B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 792.00M | 801.00M | 821.00M | 956.00M | 1.28B | 1.22B | 1.60B | 1.73B |
| Depreciation & amortization | 830.00M | 1.11B | 1.21B | 1.20B | 1.36B | 1.34B | 1.23B | 1.28B |
| Free cash flow | 12.00M | -106.00M | -3.00M | 81.00M | 212.00M | 40.00M | 834.00M | 920.00M |
| Dividends paid | -266.00M | -268.00M | 0 | -- | -- | 0 | 0 | -754.00M |
| Stock buybacks / issuance | 0 | 0 | -10.00M | -50.00M | 717.00M | 69.00M | -99.00M | -119.00M |
| Ending cash balance | 528.00M | 1.16B | 875.00M | 895.00M | 1.04B | 775.00M | 699.00M | 1.55B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 348.00M | 446.00M | 463.00M | 477.00M | 590.00M | 711.00M |
| Depreciation & amortization | 297.00M | 297.00M | 316.00M | 370.00M | 467.00M | 519.00M |
| Free cash flow | 132.00M | 235.00M | 267.00M | 286.00M | 269.00M | 395.00M |
| Dividends paid | -170.00M | -125.00M | -125.00M | -334.00M | -125.00M | -336.00M |
| Stock buybacks / issuance | -119.00M | 0 | 0 | 0 | 0 | 0 |
| Ending cash balance | 534.00M | 1.28B | 1.66B | 1.55B | 1.18B | 861.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -0.35 | 6.02 | -15.39 | 25.42 | 5.72 | -2.30 | 7.07 | 36.21 |
| ROA %i | -0.10 | 1.29 | -2.72 | 4.28 | 1.21 | -0.57 | 1.79 | 8.49 |
| ROIC %i | 3.12 | 6.19 | 0.58 | 9.14 | 5.08 | 3.02 | 5.97 | 15.10 |
| 5-year avg ROE %i | 21.22 | -2.35 | -1.58 | 3.69 | 4.28 | 3.89 | 4.10 | 14.43 |
| EBIT margin %i | 11.17 | 16.67 | 6.50 | 26.16 | 14.15 | 13.58 | 19.35 | 38.74 |
| FCF / sales %i | 0.29 | -- | -- | 1.75 | 3.77 | 0.71 | 14.37 | 15.81 |
| Current ratioi | 0.57 | 1.10 | 0.89 | 0.50 | 0.97 | 0.82 | 0.76 | 0.88 |
| Quick ratioi | 0.44 | 0.93 | 0.72 | 0.37 | 0.82 | 0.65 | 0.44 | 0.74 |
| Debt / assetsi | 44.41 | 54.80 | 54.03 | 58.85 | 55.08 | 53.32 | 49.28 | 54.89 |
| LT debt / equityi | 162.20 | 281.08 | 314.47 | 267.13 | 207.41 | 207.71 | 174.50 | 243.10 |
| Interest coveragei | 1.40 | 1.43 | 0.50 | 2.54 | 1.43 | 1.29 | 1.97 | 3.83 |
| Revenue CAGR (3Y) %i | -15.64 | 2.36 | -1.12 | 2.59 | 9.07 | 14.16 | 10.85 | 1.14 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | 5.91 | -- | -24.59 | 95.18 |
| FCF CAGR (3Y) %i | -70.03 | -- | -- | 88.99 | -- | -- | 117.55 | 63.11 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.13 | 26.39 | 30.66 | 36.21 | 37.77 | 22.20 |
| ROA %i | 2.53 | 6.52 | 7.39 | 8.49 | 7.16 | 3.73 |
| ROIC %i | 6.89 | 11.98 | 13.23 | 15.10 | 13.61 | 8.89 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.91 | 33.04 | 36.24 | 38.74 | 34.00 | 23.81 |
| FCF / sales %i | 17.15 | 16.27 | 16.00 | 15.81 | 16.42 | 16.79 |
| Current ratioi | 0.76 | 0.89 | 0.93 | 0.88 | 0.62 | 0.54 |
| Quick ratioi | 0.41 | 0.61 | 0.70 | 0.74 | 0.48 | 0.43 |
| Debt / assetsi | 52.10 | 52.85 | 54.15 | 54.89 | 56.51 | 57.55 |
| LT debt / equityi | 198.14 | 208.40 | 232.90 | 243.10 | 323.94 | 425.82 |
| Interest coveragei | 2.23 | 3.40 | 3.66 | 3.83 | 3.34 | 2.27 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-07 20:01:22 · For reference only, not investment advice and not tailored to your situation.